Treatments used in this study.
<p>The fluorescent strains used, carrying possibly mutated genes, are detailed in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1012330#pcbi.1012330.s014" target="_blank">S2 Table</a>. Target identifies the condition in the figures. RNAi treatments were performed by feeding or injection as detailed in the methods. L4440 corresponds to control conditions for RNAi treatments. Group corresponds to manual tags by function in the one-cell embryo based on papers and known phenotypes in wormbase [<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1012330#pcbi.1012330.ref079" target="_blank">79</a>]. Group abbreviations are detailed in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1012330#pcbi.1012330.g006" target="_blank">Fig 6</a>.</p> <p>(PDF)</p>
Publication Details
- Journal
- Figshare
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1371/journal.pcbi.1012330.s013
- Primary Topic
- CRISPR and Genetic Engineering
- Type
- article
- Field-Weighted Citation Impact
- 0.00